De Simone A.; Naldi M.; Tedesco D.; Bartolini M.; Davani L.; Andrisano V., Advanced analytical methodologies in Alzheimer's disease drug discovery, «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2020, 178, Article number: 112899, pp. 1 - 25 [articolo]
De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martini C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A., Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507), «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 1357 - 1357 [articolo]
De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A., Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease., «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 469 - 474 [articolo]Open Access
De Simone, Angela*; Naldi, Marina; Bartolini, Manuela; Davani, Lara; Andrisano, Vincenza, Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018, «CHROMATOGRAPHIA», 2019, 82, pp. 425 - 441 [articolo]
De Simone A.; Naldi M.; Tedesco D.; Milelli A.; Bartolini M.; Davani L.; Widera D.; Dallas M.L.; Andrisano V., Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts, «ACS OMEGA», 2019, 4, pp. 12308 - 12318 [articolo]Open Access
